Evidence map›Paper›PMID 38454547›Full record

ArticleClinical genetics2024

Homozygous novel truncating variant of CLPP associated with severe Perrault syndrome.

Rabia Faridi, Pamela Stratton, Noemi Salmeri, Robert J Morell, Asma Ali Khan, Muhammad A Usmani, William G Newman, Sheikh Riazuddin, Thomas B Friedman

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Clinical genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Mitochondrial Protease ClpP: Cancer Marker and Drug Target.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Rabia FaridiLaboratory of Molecular Genetics, NIDCD, NIH, Bethesda, Maryland, USA.ORCID 0000-0001-7788-8755
Pamela StrattonOffice of the Clinical Director, Intramural Research Program, NINDS, NIH, Bethesda, Maryland, USA.
Noemi SalmeriRehabilitation Medicine Department, Clinical Center, NIH, Bethesda, Maryland, USA.
Robert J MorellGenomics and Computational Biology Core, NIDCD, NIH, Bethesda, Maryland, USA.
Asma Ali KhanNational Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Muhammad A UsmaniAllama Iqbal Medical Research Center, Jinnah Burn and Reconstructive Surgery Center, University of Health Sciences, Lahore, Pakistan.
William G NewmanEvolution, Infection and Genomics, University of Manchester, Manchester, UK.ORCID 0000-0002-6382-4678
Sheikh RiazuddinAllama Iqbal Medical Research Center, Jinnah Burn and Reconstructive Surgery Center, University of Health Sciences, Lahore, Pakistan.ORCID 0000-0001-6012-0192
Thomas B FriedmanLaboratory of Molecular Genetics, NIDCD, NIH, Bethesda, Maryland, USA.ORCID 0000-0003-4614-6630
National Institutes of Health · USAllama Iqbal Medical College · PKNational Institutes of Health Clinical Center · USOffice of the Director · USUniversity of Manchester · GBUniversity of the Punjab · PK

Funding

Identification of Genes Causing Syndromic And Nonsyndromic Hearing ImpairmentZIADC000039 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI FRIEDMAN, THOMAS · 2009 to 2025
$48.7M
Myosin XVA and Other Genes Essential for Stereocilia MorphogenesisZIADC000048 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI FRIEDMAN, THOMAS · 2009 to 2025
$23.6M
Genomic and Computational Biology Support for NIDCD Intramural ResearchZICDC000086 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI MORELL, ROBERT J · 2015 to 2025
$19.8M
Identification of Genes Causing Syndromic And Nonsyndromic Hearing ImpairmentZ01DC000039 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI FRIEDMAN, THOMAS BAER · 1997 to 2008
$7.2M
SPEECH AND HEARING SCIENCEST32DC000039 · NIDCD · CUNY GRADUATE SCH AND UNIV CTR · PI SCHWARTZ, RICHARD G · 1992 to 2002
$429k
Intramural NIH HHS Z01 DC000039Medical Research Council MR/W019027/1NIDCD NIH HHS T32 DC000039
6 · The paper itself

Abstract

A female proband and her affected niece are homozygous for a novel frameshift variant of CLPP. The proband was diagnosed with severe Perrault syndrome encompassing hearing loss, primary ovarian insufficiency, abnormal brain white matter and developmental delay.

Indexed as

Gonadal Dysgenesis, 46,XXHearing Loss, SensorineuralFemaleHomozygoteHumansPedigreeCLPPdeafnessdevelopmental delayovarian dysgenesisPerrault syndrome

Identifiers

PMID38454547
PMCPMC10990821
OpenAlexW4392591909

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.